文献速递颅颌面外科显微修复重建

应用Scarpa筋膜移植物加固黏骨膜袋的二期牙槽骨植骨:一项回顾性对照结局研究

Reinforcing the Mucoperiosteal Pocket with the Scarpa Fascia Graft in Secondary Alveolar Bone Grafting: A Retrospective Controlled Outcome Study.
PubMed 文献 · Plast Reconstr Surg · 2017-01-01

该回顾性对照研究纳入74例单侧完全性唇腭裂患者,比较Scarpa筋膜移植物加固黏骨膜袋的改良二期牙槽骨植骨与对照组的临床成功率及感染率。Scarpa筋膜组临床成功率(Bergland I+II型)显著更高(67.6% vs 94.6%),感染率显著更低(16.2% vs 2.7%),Bergland与Witherow量表高度相关(0.964;p < 0.001)。作者认为该新方法安全有效,成功率居已报道的高水平之列。

要点

  • Scarpa筋膜组临床成功率(Bergland I+II型)为94.6%,对照组为67.6%。
  • Scarpa筋膜组感染率为2.7%,对照组为16.2%。
  • Scarpa筋膜组无伤口裂开、瘘、骨移植物暴露或额外供区并发症。

核心结论

  • 作者认为应用Scarpa筋膜移植物的牙槽骨植骨新方法安全有效,且成功率居已报道的高水平之列。

研究设计与样本

  • 回顾性对照研究,纳入74例单侧完全性唇腭裂患者,分为等样本量的Scarpa筋膜组与对照组,两组均为连续接受二期牙槽骨植骨的单侧完全性唇腭裂患者。
  • 术后至少1年拍摄的牙槽裂咬合片用于评估Spearman相关的Bergland与Witherow量表。
  • 统计采用t检验、卡方检验和比值比。

主要发现

  • Scarpa筋膜组临床成功率(Bergland I+II型)为94.6%,对照组为67.6%,Scarpa筋膜组显著更高。
  • Scarpa筋膜组感染率为2.7%,对照组为16.2%,Scarpa筋膜组显著更低。
  • Bergland与Witherow量表高度相关(0.964;p < 0.001)。
  • Scarpa筋膜组无伤口裂开、瘘、骨移植物暴露或额外供区并发症。

关键数值与推荐

  • 临床成功以Bergland I型和II型定义。
  • 证据等级为治疗性,III级。

临床怎么用

  • 作者认为该新方法安全有效,成功率居已报道的高水平之列。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Secondary alveolar bone grafting is the gold standard for the treatment of alveolar clefts in cleft lip and palate patients. The authors present a modified method using a Scarpa fascia graft that is placed deep into the mucoperiosteal pocket for watertight sealing of the bone graft chamber and limiting the graft position to the alveolar region for bony stability and tooth support. The outcome was assessed for clinical success in terms of bone graft stability and infection rate. METHODS: Seventy-four unilateral complete cleft lip and palate patients were enrolled in this retrospective study consisting of equal-size Scarpa fascia and control groups of consecutive unilateral complete cleft lip and palate patients undergoing secondary alveolar bone grafting. Occlusal radiographs of the alveolar cleft taken at least 1 year postoperatively were evaluated for Spearman correlated Bergland and Witherow scales. Statistical evaluation was conducted using t test, chi-square test, and odds ratio. RESULTS: The clinical success rate (Bergland types I and II) of the Scarpa fascia procedure was significantly higher (67.6 versus 94.6 percent, respectively), with a significantly lower infection rate (16.2 versus 2.7 percent, respectively) and a high correlation of Bergland and Witherow scales (0.964; p < 0.001). There was no wound dehiscence, fistula, bone graft exposure, or additional donor-site morbidity in the Scarpa fascia group. CONCLUSION: The authors' new method of alveolar bone grafting with the Scarpa fascia graft is safe and effective, and has one of the highest documented success rates. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Lonic D, Yamaguchi K, Chien-Jung Pai B, et al. Reinforcing the Mucoperiosteal Pocket with the Scarpa Fascia Graft in Secondary Alveolar Bone Grafting: A Retrospective Controlled Outcome Study. Plast Reconstr Surg. 2017. PMID: 28953729. doi:10.1097/PRS.0000000000003696

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。